Par Pharmaceutical on Wednesday announced that it has begun shipping its generic version of AbbVie’s AnroGel (testosterone gel 1%) in 2.5-g and 5-g foil packets.
he campaign is being undertaken in partnership with the American Chronic Pain Association, the Pain Community, the U.S. Pain Foundation and the American Academy of Pain Management.
PrescribeMedicare is meant to serve as a tool for patients in 2016 when open enrollment for plan choices begins.
The guidance was outlined in a blog post by Janet Woodcock, director of the FDA’s center for drug evaluation and research, and Karen Midthum, director of the FDA’s center for biologics evaluation and research.
Mylan will now move forward with its plans to tender a formal offer directly to Perrigo’s shareholders.
Aurobindo Pharma Limited announced Thursday that it had received approval from the Food and Drug Administration for its entecavir tablets in 0.5- and 1-mg dosage strengths.
Mylan this week announced the launch of its generic version of Pfizer’s Zosyn (piperacillin and tazobactam) injection.
Camber Pharmaceuticals last week announced its introduction of its entecavir tablet in 0.5- and 1-mg dosage strengths.
IMS Health’s Doug Long gave an overview of the present state of the U.S. pharmaceutical market and where it might be headed in the coming months and years at NACDS Total Store Expo on Sunday.